Other Species / Isoforms
  GADS (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K36-ub
SNQEEWFkAELGsQE
0 2
GADS (human) SNQEEWFkAELGsQE K36-ub
GADS (mouse) SNQEEWLKAELGSQE K36
GADS (rat) SNQEEWLKAELGSQE K36
S41-p
WFkAELGsQEGyVPk
0 7
GADS (human) WFkAELGsQEGyVPk S41-p
GADS (mouse) WLKAELGSQEGYVPK S41
GADS (rat) WLKAELGSQEGYVPK S41
Y45-p
ELGsQEGyVPkNFID
Upstream
0 89
Treatment
  • anti-CD28
  • anti-CD3
GADS (human) ELGsQEGyVPkNFID Y45-p
GADS (mouse) ELGSQEGYVPKNFID Y45
GADS (rat) ELGSQEGYVPKNFID Y45
K48-ub
sQEGyVPkNFIDIQF
0 2
GADS (human) sQEGyVPkNFIDIQF K48-ub
GADS (mouse) SQEGYVPKNFIDIEF K48
GADS (rat) SQEGYVPKNFIDIKF K48
K57-ub
FIDIQFPkWFHEGLS
0 1
GADS (human) FIDIQFPkWFHEGLS K57-ub
GADS (mouse) FIDIEFPEWFHEGLS E57
GADS (rat) FIDIKFPEWFHEGLS E57
K106-ac
EDDVQHFkVMRDNkG
0 1
GADS (human) EDDVQHFkVMRDNkG K106-ac
GADS (mouse) EDDVQHFKVMRDTKG K106
GADS (rat) EDDVQHFKVMRDTKG K106
K112-ub
FkVMRDNkGNYFLWT
0 2
GADS (human) FkVMRDNkGNYFLWT K112-ub
GADS (mouse) FKVMRDTKGNYFLWT K112
GADS (rat) FKVMRDTKGNYFLWT K112
K121-ub
NYFLWTEkFPSLNkL
0 1
GADS (human) NYFLWTEkFPSLNkL K121-ub
GADS (mouse) NYFLWTEKFPSLNKL K121
GADS (rat) NYFLWTEKFPSLNKL K121
K127-ub
EkFPSLNkLVDyYRT
0 1
GADS (human) EkFPSLNkLVDyYRT K127-ub
GADS (mouse) EKFPSLNKLVDYYRT K127
GADS (rat) EKFPSLNKLVDYYRT K127
Y131-p
SLNkLVDyYRTNSIS
0 1
GADS (human) SLNkLVDyYRTNSIS Y131-p
GADS (mouse) SLNKLVDYYRTTSIS Y131
GADS (rat) SLNKLVDYYRTTSIS Y131
K141-ub
TNSISRQkQIFLRDR
0 2
GADS (human) TNSISRQkQIFLRDR K141-ub
GADS (mouse) TTSISKQKQVFLRDG K141
GADS (rat) TTSISKQKQIFLRDG K141
S159-p
DQGHRGNsLDRRsQG
0 2
GADS (human) DQGHRGNsLDRRsQG S159-p
GADS (mouse) DQGHRGNsLDRRSQG S158-p
GADS (rat) QQGHRGNSLDRRTQG S159
S164-p
GNsLDRRsQGGPHLS
0 5
GADS (human) GNsLDRRsQGGPHLS S164-p
GADS (mouse) GNsLDRRSQGGPHPS S163
GADS (rat) GNSLDRRTQGGPPRE T164
S181-p
VGEEIRPsMNRKLsD
0 5
GADS (human) VGEEIRPsMNRKLsD S181-p
GADS (mouse) VGEEIRPSVNRKLsD S180
GADS (rat) AGEEIRPLMNRKLSD L184
S187-p
PsMNRKLsDHPPtLP
0 78
GADS (human) PsMNRKLsDHPPtLP S187-p
GADS (mouse) PSVNRKLsDHLPLGP S186-p
GADS (rat) PLMNRKLSDHLPLGT S190
T192-p
KLsDHPPtLPLQQHQ
0 25
GADS (human) KLsDHPPtLPLQQHQ T192-p
GADS (mouse) KLsDHLPLGPQQFHP L191
GADS (rat) KLSDHLPLGTQQFHP L195
Y207-p
HQPQPPQyAPAPQQL
0 87
GADS (human) HQPQPPQyAPAPQQL Y207-p
GADS (mouse) HQQPSPQFTPGPQPP F206
GADS (rat) HQQLPPQFPPGPQPP F210
Y222-p
QQPPQQRyLQHHHFH
Upstream
0 64
Treatment
  • anti-CD3
GADS (human) QQPPQQRyLQHHHFH Y222-p
GADS (mouse) QPPQQQRYLQHFHQD Y218
GADS (rat) QPPPQQRYLQHFHQD Y222
R233-m1
HHFHQERrGGsLDIN
0 1
GADS (human) HHFHQERrGGsLDIN R233-m1
GADS (mouse) QHFHQDRRGGsLDIN R227
GADS (rat) QHFHQDRRGGSLDIN R231
S236-p
HQERrGGsLDINDGH
0 62
GADS (human) HQERrGGsLDINDGH S236-p
GADS (mouse) HQDRRGGsLDINDGH S230-p
GADS (rat) HQDRRGGSLDINDGH S234
T246-p
INDGHCGtGLGsEMN
0 3
GADS (human) INDGHCGtGLGsEMN T246-p
GADS (mouse) gap -
GADS (rat) gap -
S250-p
HCGtGLGsEMNAALM
0 2
GADS (human) HCGtGLGsEMNAALM S250-p
GADS (mouse) DGHCGLGSEVNATLM S242
GADS (rat) DGHLGIGSEMNATLM S246
T262-p
ALMHRRHtDPVQLQA
Upstream
Downstream
2 158
Effects on Modified Protein
  • activity, inhibited
  • intracellular localization
  • phosphorylation
Treatment
  • anti-CD28
GADS (human) ALMHRRHtDPVQLQA T262-p
GADS (mouse) TLMHRRHtDPVQLQA T254-p
GADS (rat) TLMHRRHtDPVQLQA T258-p
Y324-p
LGLFPANyVAPMTR_
0 7
GADS (human) LGLFPANyVAPMTR_ Y324-p
GADS (mouse) LGLFPANYVAPMMR_ Y316
GADS (rat) LGLFPANYVAPMMR_ Y320